De-Risking Drug Discovery Programmes Early with ADMET

Synthesis and Evaluation of Antihyperglycemic Activity of 1, 4-Benzothiazepine-2-One Derivatives in Alloxan Induced Diabetic Rats

“…In the drug development process, most of the developed drug molecules failed in the clinical phases due to their poor pharmacokinetics and toxicity [20] . Thus, it is always beneficial to point out such failures at early stage of drug development.…”